| Otolaryngology |
1 |
1 |
| Antihistamine |
0 |
0.95 |
| Allergy |
0 |
0.9 |
| Allergic Rhinitis |
0 |
0.45 |
| Food and Drug Administration (FDA) |
0 |
0.95 |
| Child |
0 |
0.21 |
| Steroids |
0 |
0.15 |
| Nose |
0 |
0.1 |
| Sedative |
0 |
0.1 |
| Patient Safety |
0 |
0.09 |
| Revenue and Practice Management |
0 |
0.09 |
| Xerostomia |
0 |
0.07 |
| Adverse Effects |
0 |
0.05 |
| Dentistry and Oral Health |
0 |
0.05 |
| Dorsum |
0 |
0.05 |
| Grant |
0 |
0.05 |
| Health Care Quality, Access, and Evaluation |
0 |
0.05 |
| Mouth |
0 |
0.05 |
| Pennsylvania |
0 |
0.05 |
| Private Practice |
0 |
0.05 |
| Rhinitis |
0 |
0.05 |
| Self-Medication |
0 |
0.05 |
| Social Determinants of Health |
0 |
0.05 |